Showa Chemical Industry Co., Ltd. (TYO:4990)
480.00
-5.00 (-1.03%)
Jun 4, 2026, 10:05 AM JST
Showa Chemical Industry Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 2,973 | 3,172 | 3,149 | 2,992 | 3,248 |
Cash & Short-Term Investments | 2,973 | 3,172 | 3,149 | 2,992 | 3,248 |
Cash Growth | -6.27% | 0.73% | 5.25% | -7.88% | 4.50% |
Receivables | 2,310 | 2,446 | 2,696 | 2,810 | 2,337 |
Inventory | 1,119 | 1,100 | 1,037 | 994 | 900 |
Other Current Assets | 47 | 71 | 102 | 97 | 47 |
Total Current Assets | 6,449 | 6,789 | 6,984 | 6,893 | 6,532 |
Property, Plant & Equipment | 2,732 | 2,612 | 2,489 | 2,529 | 2,597 |
Long-Term Investments | 5,238 | 4,081 | 3,851 | 3,371 | 3,235 |
Other Intangible Assets | 68 | 90 | 124 | 76 | 41 |
Long-Term Deferred Tax Assets | 24 | 23 | 20 | 108 | 144 |
Other Long-Term Assets | 1 | 2 | 1 | 1 | 2 |
Total Assets | 14,569 | 13,655 | 13,528 | 13,039 | 12,613 |
Accounts Payable | 932 | 996 | 1,217 | 1,039 | 859 |
Accrued Expenses | 102 | 100 | 45 | 44 | 43 |
Short-Term Debt | 1,244 | 1,581 | 2,092 | 2,379 | 2,694 |
Current Portion of Long-Term Debt | 384 | 524 | 398 | 418 | 528 |
Current Portion of Leases | - | - | - | - | 9 |
Current Income Taxes Payable | 133 | 126 | 96 | 82 | 53 |
Other Current Liabilities | 396 | 339 | 339 | 425 | 301 |
Total Current Liabilities | 3,191 | 3,666 | 4,187 | 4,387 | 4,487 |
Long-Term Debt | 653 | 778 | 722 | 845 | 939 |
Pension & Post-Retirement Benefits | 841 | 911 | 872 | 906 | 906 |
Long-Term Deferred Tax Liabilities | 405 | 88 | 55 | 44 | 58 |
Other Long-Term Liabilities | 92 | 93 | 94 | 99 | 102 |
Total Liabilities | 5,182 | 5,536 | 5,930 | 6,281 | 6,492 |
Common Stock | 598 | 598 | 598 | 598 | 598 |
Additional Paid-In Capital | 566 | 566 | 566 | 574 | 574 |
Retained Earnings | 6,550 | 5,989 | 5,694 | 5,205 | 4,653 |
Treasury Stock | -383 | -383 | -383 | -421 | -421 |
Comprehensive Income & Other | 2,056 | 1,349 | 1,123 | 800 | 716 |
Total Common Equity | 9,387 | 8,119 | 7,598 | 6,756 | 6,120 |
Minority Interest | - | - | - | 2 | 1 |
Shareholders' Equity | 9,387 | 8,119 | 7,598 | 6,758 | 6,121 |
Total Liabilities & Equity | 14,569 | 13,655 | 13,528 | 13,039 | 12,613 |
Total Debt | 2,281 | 2,883 | 3,212 | 3,642 | 4,170 |
Net Cash (Debt) | 692 | 289 | -63 | -650 | -922 |
Net Cash Growth | 139.45% | - | - | - | - |
Net Cash Per Share | 64.97 | 27.14 | -5.94 | -61.38 | -87.10 |
Filing Date Shares Outstanding | 10.65 | 10.65 | 10.65 | 10.59 | 10.59 |
Total Common Shares Outstanding | 10.65 | 10.65 | 10.65 | 10.59 | 10.59 |
Working Capital | 3,258 | 3,123 | 2,797 | 2,506 | 2,045 |
Book Value Per Share | 881.36 | 762.30 | 713.39 | 637.91 | 577.86 |
Tangible Book Value | 9,319 | 8,029 | 7,474 | 6,680 | 6,079 |
Tangible Book Value Per Share | 874.97 | 753.85 | 701.74 | 630.73 | 573.99 |